| Jul 17 |
Nuwellis reports first commercial sale of Quelimmune therapy to Cincinnati Children’s
|
| Jul 17 |
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
|
| Jul 12 |
SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
|
| Jul 9 |
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
|
| Jul 9 |
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
|
| Jul 1 |
Nuwellis files for $25M mixed securities shelf
|
| Jun 26 |
Nuwellis to implement 1-for-35 reverse stock split
|
| Jun 26 |
Nuwellis Announces Reverse Stock Split
|
| Jun 25 |
Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
|
| Jun 6 |
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
|
